Hollis-Eden management update

Hollis-Eden Pharmaceuticals Inc. (NASDAQ:HEPH), San Diego, Calif. Business: Endocrine, Autoimmune, Cancer Transitioned: James Frincke to interim CEO while remaining COO; he replaces Richard Hollis, wh...